Acro Biomedical Co. Ltd. (ACBM)
0.026
0.00 (0.00%)
USD |
OTCM |
Aug 21, 16:00
Acro Biomedical Total Liabilities (Quarterly) : 0.4484M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.4484M |
| March 31, 2026 | 0.4311M |
| December 31, 2025 | 0.4011M |
| September 30, 2025 | 0.4369M |
| June 30, 2025 | 0.3708M |
| March 31, 2025 | 0.3291M |
| December 31, 2024 | 0.3269M |
| September 30, 2024 | 0.3242M |
| June 30, 2024 | 0.3217M |
| March 31, 2024 | 0.3181M |
| December 31, 2023 | 0.3155M |
| September 30, 2023 | 0.2586M |
| June 30, 2023 | 0.1995M |
| March 31, 2023 | 0.246M |
| December 31, 2022 | 0.2011M |
| September 30, 2022 | 0.1515M |
| June 30, 2022 | 0.0944M |
| March 31, 2022 | 0.0854M |
| December 31, 2021 | 0.1174M |
| Date | Value |
|---|---|
| September 30, 2021 | 0.0616M |
| June 30, 2021 | 0.0602M |
| March 31, 2021 | 0.31M |
| December 31, 2020 | 0.3122M |
| September 30, 2020 | 0.2436M |
| June 30, 2020 | 0.1813M |
| March 31, 2020 | 0.1397M |
| December 31, 2019 | 0.1339M |
| September 30, 2019 | 0.1958M |
| June 30, 2019 | 0.1331M |
| March 31, 2019 | 0.1413M |
| September 30, 2018 | 0.2407M |
| June 30, 2018 | 0.2328M |
| March 31, 2018 | 0.2069M |
| December 31, 2017 | 0.173M |
| September 30, 2017 | 0.037M |
| June 30, 2017 | 0.0307M |
| March 31, 2017 | 0.0183M |
| December 31, 2016 | 0.0246M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Exlites Holdings International, Inc. | 0.1038M |
| Xcelerate, Inc. | 2.332M |
| PD-Rx Pharmaceuticals, Inc. | -- |
| Vivos Therapeutics, Inc. | 28.13M |
| Stella Diagnostics, Inc. | 29.06M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 0.0036M |
| Shareholders Equity (Quarterly) | -0.4448M |
| Debt to Equity Ratio | -0.8665 |
| Current Ratio | 0.008 |
| Net Debt Paydown Yield | -2.81% |